These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 736748)

  • 21. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
    Tanaka F; Wada H
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
    Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA
    J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fundamental study and clinical testing of human tumor clonogenic assay (HTCA)].
    Sasaki Y; Saijo N; Eguchi K; Futami H; Suga J; Miyaoka H; Sano T; Sakurai M; Shinkai T; Tominaga K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1185-93. PubMed ID: 3729440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro chemosensitivity testing of human tumours by collagen gel droplet culture and image analysis.
    Tanigawa N; Kitaoka A; Yamakawa M; Tanisaka K; Kobayashi H
    Anticancer Res; 1996; 16(4A):1925-30. PubMed ID: 8712722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on in vitro testing on new drugs in ovarian cancer and melanoma.
    Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
    Cancer Treat Rep; 1981; 65(5-6):532-3. PubMed ID: 7195308
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R; Rosen F; Abramson I; Venditti J; Howell S
    Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prediction of the clinical response of ovarian cancer to chemotherapy using an in vitro anticancer drug sensitivity test].
    Li ZX
    Zhonghua Fu Chan Ke Za Zhi; 1988 Sep; 23(5):287-9, 318. PubMed ID: 3250811
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening].
    Zhukova OS; Dobrynin IaV
    Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curative cancer chemotherapy.
    Frei E
    Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
    Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature.
    Tropé C; Kaern J
    J Clin Oncol; 2007 Jul; 25(20):2909-20. PubMed ID: 17617522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human tumor stem cell assay].
    Inoue K; Arakawa M; Ogawa M
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):599-605. PubMed ID: 7184417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy in the treatment of ovarian cancer. (the cancer-chemotherapy-sensitvity-test).
    Limburg H
    Nihon Sanka Fujinka Gakkai Zasshi; 1969 Aug; 21(8):907-8. PubMed ID: 5388529
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adjuvant therapy in surgery of lung cancer--evaluation of chemotherapy].
    Yamaguchi Y; Matsumura K; Sato K; Hayashi Y
    Nihon Kyobu Geka Gakkai Zasshi; 1978 Mar; 26(3):334-6. PubMed ID: 701885
    [No Abstract]   [Full Text] [Related]  

  • 38. In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.
    Alberts DS; Samon SE; Chen HS; Surwit EA; Soehnlen B; Young L; Moon TE
    Lancet; 1980 Aug; 2(8190):340-2. PubMed ID: 6105478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug selection for adjuvant chemotherapy--sensitivity test].
    Ito M
    Nihon Kyobu Geka Gakkai Zasshi; 1978 Mar; 26(3):336-8. PubMed ID: 701886
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacologic assessment of regimen chemosensitivity in the soft-agar assay: effect of oxygen on human tumors.
    Fan D; Morgan LR; Schneider C; Blank H; Roy S; Wang YF; Fan S
    J Cancer Res Clin Oncol; 1985; 110(3):209-15. PubMed ID: 3841126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.